儿童相对年龄与ADHD药物使用:芬兰人群研究
该研究基于芬兰2005至2007年出生儿童的人群数据,分析出生月份与ADHD药物使用的关系。
要点
- 关联在入学初期更明显,提示相对不成熟的影响。
核心结论
- 相对不成熟增加芬兰儿童ADHD药物使用的可能性,且关联在入学初期更明显。
研究设计与样本
- 基于芬兰2005至2007年出生儿童的人群研究,病例为首次购买ADHD药物者(n=7054),采用Cox比例风险模型分析出生月份和性别与ADHD药物使用的关联。
临床怎么用
- 临床医生和教师应意识到相对年龄与ADHD药物使用风险的关联,尤其在入学初期。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The youngest children in a classroom are at increased risk of being medicated for attention-deficit/hyperactivity disorder (ADHD). We examined the association between children's birth month and ADHD medication rates in Finland. METHODS: Using a population-based study, we analyzed ADHD medication use among children born in 2005 to 2007. Cases (n = 7054) were identified from the first purchase of medication for ADHD. Cox proportional hazard models and hazard ratios (HRs) were examined by birth month and sex. Finnish children start first grade in the year of their seventh birthday. The cutoff date is December 31. RESULTS: Risk of ADHD medication use increased throughout the year by birth month (ie, January through April to May through August to September through December). Among boys born in September to December, the association remained stable across cohorts (HR: 1.3; 95% confidence interval [CI]: 1.1-1.5). Among girls born in September to December, the HR in the 2005 cohort was 1.4 (95% CI: 1.1-1.8), whereas in the 2007 cohort it was 1.7 (95% CI: 1.3-2.2). In a restricted follow-up, which ended at the end of the year of the children's eighth birthday, the HRs for boys and girls born in September to December 2007 were 1.5 (95% CI: 1.3-1.7) and 2.0 (95% CI: 1.5-2.8), respectively. CONCLUSIONS: Relative immaturity increases the likelihood of ADHD medication use in Finland. The association was more pronounced during the first school years. Increased awareness of this association is needed among clinicians and teachers.
引用
- Vuori M, Martikainen JE, Koski-Pirilä A, et al. Children's Relative Age and ADHD Medication Use: A Finnish Population-Based Study. Pediatrics. 2020. PMID: 32958613. doi:10.1542/peds.2019-4046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。